Search

everythinglearnresearchcommunity

for

Search:↓

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

Adalimumab is the most effective treatment for severe hidradenitis suppurativa, but more research is needed to improve treatment options.

Systemic retinoids do not increase COVID-19 risk or severity.

A 16-year-old girl with autoimmune hemolytic anemia and deep vein thrombosis improved with treatment, possibly indicating systemic lupus erythematosus.

A woman with skin and joint issues progressed from one type of lupus to another, highlighting the need to recognize complex conditions.

Chronic granulomatous disease may be linked to developing systemic lupus erythematosus.

A woman with lupus had rare severe symptoms but improved with treatment.

SLE and DM can coexist but are rare and need careful evaluation.

Recognizing unusual brain and skin symptoms is crucial for diagnosing lupus early.

Oral ulcers are common in SLE patients and often link to other symptoms.

No single biomarker is reliable enough for diagnosing and assessing SLE.

Nanoemulsions can effectively deliver antiseptic agents deep into the skin.

Systemic corticosteroids can help treat rapidly spreading vitiligo but require more research for safer use.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

Natural products like propolis are causing more skin allergies, and certain skin treatments and medications have various side effects and risks.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

Minoxidil use in children may cause heart issues.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

Systemic diseases can cause hair loss, which is often reversible with treatment.

Finasteride microspheres help reduce hair loss for up to eight weeks with fewer side effects.

Belimumab effectively controls SLE disease activity and reduces steroid use.

A child with low platelets and anemia was later found to have lupus.

A girl initially thought to have a psychiatric disorder was later found to have a lupus-related condition, which improved with proper treatment.

Various treatments, including FDA-approved drugs, natural products, and oral supplements, can help with hair loss, but a patient's medical history and potential allergies should be considered when choosing a treatment.

Hair changes can indicate systemic diseases or medication effects.

Skin problems can indicate different diseases inside the body.

The mouse models are effective for testing new hair loss treatments.

No FDA-approved treatments for chemotherapy-induced hair loss existed in 2006; more research was needed.

Different treatments for skin conditions were found to be effective and generally safe, with biologics recommended as the first choice for generalized pustular psoriasis.

Low-dose methotrexate effectively regrows hair in many alopecia areata patients but can cause some side effects.